Jeffrey S Glenn is of Eiger BioPharmaceuticals, Inc.. Currently has a direct ownership of 182,355 shares of EIGR, which is worth approximately $2.31 Million. The most recent transaction as insider was on Dec 22, 2022, when has been sold 100,000 shares (Common Stock) at a price of $1.28 per share, resulting in proceeds of $128,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 182K
0% 3M change
0% 12M change
Total Value Held $2.31 Million

Jeffrey S Glenn Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 22 2022
BUY
Open market or private purchase
$128,000 $1.28 p/Share
100,000 Added 35.42%
182,355 Common Stock
Mar 11 2022
BUY
Grant, award, or other acquisition
-
6,000 Added 6.79%
82,355 Common Stock
Mar 12 2021
BUY
Grant, award, or other acquisition
-
5,000 Added 6.15%
76,355 Common Stock
JSG

Jeffrey S Glenn

Palo Alto, CA

Track Institutional and Insider Activities on EIGR

Follow Eiger BioPharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EIGR shares.

Notify only if

Insider Trading

Get notified when an Eiger Bio Pharmaceuticals, Inc. insider buys or sells EIGR shares.

Notify only if

News

Receive news related to Eiger BioPharmaceuticals, Inc.

Track Activities on EIGR